| Warren T Anderson, MD | |
|
300 Wedgewood Drive, Morgantown, WV 26505 | |
| (304) 599-8802 | |
| (304) 599-5607 |
| Full Name | Warren T Anderson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 300 Wedgewood Drive, Morgantown, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376627315 | NPI | - | NPPES |
| 0086216000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 11100 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Warren T Anderson, MD 300 Wedgewood Drive, Morgantown, WV 26505 Ph: (304) 599-8802 | Warren T Anderson, MD 300 Wedgewood Drive, Morgantown, WV 26505 Ph: (304) 599-8802 |
News Archive
Researchers at Oregon State University have discovered a group of genes in one species of snail that provide a natural resistance to the flatworm parasite that causes schistosomiasis, and opens the door to possible new drugs or ways to break the transmission cycle of this debilitating disease.
Americans for Responsible Heath Care is launching an independent television advertisement campaign in the Boston media market to educate Americans about the dangerous health care proposal being debated in Congress.
Qnexa took a step closer to approval on Wednesday, when outside advisers to the U.S. Food and Drug Administration voted 20-to-2 in favor of approval. The panel also recommended the company conduct a study to scrutinize even more closely any risk of heart problems. That study may be required after the drug is approved. Should the FDA ask for further data on heart risks before any approval, it would delay Qnexa's launch further.
Actavis Group, an international generic pharmaceuticals company, today announced that it recently received approval from the US Food & Drug Administration to market Methylphenidate Hydrochloride Extended-Release Capsules (LA) CII, USP, 20mg, 30mg, and 40mg. Actavis has first-to-file exclusivity on the 20mg, 30mg, and 40mg strengths.
A major 20-year study by psychologists and dentists has cast doubt on the assumption that orthodontic treatment improves psychological well-being.
› Verified 1 days ago
Rohma Shamsi, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-4125 | |
Islam Younes, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 | |
Dr. David Weissman, M. D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800 Fax: 304-293-6963 | |
Dr. Madhavi Kadiyala, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4000 | |
Dr. Swapna Gayam, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-4123 Fax: 304-293-2135 | |
Monika Maximilliane Holbein, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-594-4000 | |
Nour Daboul, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 |